Consuming too much salt has long been recognized as a primary catalyst for cardiovascular strain, most notably through its direct link to hypertension. However, a growing body of scientific evidence suggests that the consequences of an excessive sodium diet extend far beyond the heart and blood vessels. Researchers are increasingly finding that high salt intake can actively interfere with critical neurological processes, including memory retention, complex thinking, and emotional well-being. Because high salt consumption remains a persistent global public health challenge, identifying mechanisms to mitigate its damaging physiological footprint has become an urgent priority for the medical and scientific communities.
In a promising new development, researchers in Japan have identified a potential therapeutic ally in LPC70, a specialized compound derived from soybeans. While earlier foundational research established that this unique ingredient could successfully suppress high blood pressure and cognitive deficits associated with high-salt diets in laboratory mice, the exact mechanisms remained elusive. A comprehensive new study dives deeper into these physiological pathways, revealing precisely how the soy-derived compound influences vital chemical signaling networks located within both the brain and the kidneys.
How a Soy Compound May Counter the Effects of Excess Salt
The investigation centers heavily on prostaglandins, a family of local signaling molecules synthesized from arachidonic acid, a fundamental fatty acid. These substances function much like localized hormones, orchestrating and regulating essential physiological operations throughout the entire body.
Within the cardiovascular system, prostaglandins play a definitive role in managing blood pressure by carefully balancing the constriction and dilation of blood vessels. Their functions within the central nervous system, however, are considerably more intricate. Depending strictly upon which specific cellular receptors they activate, these signaling molecules can either trigger protective pathways that safeguard fragile nerve cells or provoke detrimental processes capable of disrupting memory, cognition, and emotional regulation.
LPC70 is a specialized form of soy lysolecithin in which lysophosphatidylcholine constitutes more than 70 percent of the total phospholipid content. Although preceding laboratory experiments demonstrated that LPC70 could alleviate salt-induced hypertension and cognitive decline, scientists lacked a clear understanding of the underlying molecular machinery—particularly its precise impact on prostaglandin signaling pathways.
To bridge this knowledge gap, a dedicated research team led by Professor Akihiro Mouri and Dr. Hisayoshi Kubota, in close collaboration with Dr. Kazuhiro Kagotani, set out to examine how LPC70 systematically alters these pathways in murine models subjected to a high-salt diet.
Dr. Kubota, who served as the study’s first author, was instrumental in executing the experimental design. He systematically evaluated blood pressure fluctuations, observed nuanced behavioral modifications, and quantified the molecular activity tied directly to prostaglandin pathways. His rigorous analytical work helped illuminate how LPC70 generates differential, organ-specific effects in the precise physiological systems responsible for salt-driven cardiovascular and cognitive deterioration.
Prof. Mouri and Dr. Kubota conduct their academic and research pursuits within the Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices at the Fujita Health University Graduate School of Medical Science, alongside their affiliations with the International Center for Brain Science at Fujita Health University in Japan. Meanwhile, Dr. Kagotani contributes his expertise through his work with Tsuji Oil Mills Co., Ltd., and the Tsuji Health and Beauty Science Laboratory at Mie University in Japan.
The resulting findings were officially released online on May 14, 2026, and subsequently published in Volume 197 of the academic journal Neurochemistry International on July 1, 2026.
"We wanted to understand the role of LPC70 in coordinating changes in PG signaling across organ systems," remarked Prof. Mouri, elaborating on the conceptual origins of the project. "Our study originated from a collaborative research project with Tsuji Oil Mills Co., Ltd, a company that develops naturally derived food ingredients," he added.
Soy Compound Improves Blood Pressure and Memory in Mice
As anticipated by the research team, mice subjected to a continuous high-salt diet rapidly developed elevated systemic blood pressure. However, the pathological consequences of the sodium-rich regimen extended well beyond simple cardiovascular strain.
Behavioral evaluations revealed that the animals also experienced a noticeable decline in social interactivity alongside distinct difficulties in recognizing familiar objects they had previously encountered, signaling clear impairments in recognition memory. Interestingly, the mice retained normal general locomotor activity and displayed no substantial spikes in anxiety-like behaviors. This specific behavioral profile strongly indicates that excessive dietary salt selectively disrupts higher-order cognitive and social processing rather than inducing widespread, non-specific neurological impairment.
When the researchers introduced LPC70 as a dietary supplement to these high-salt cohorts, a marked reversal of these adverse effects occurred. Not only did the animals experience measurable improvements in blood pressure regulation, but they also performed significantly better on standardized behavioral tests assessing social interaction and object recognition memory.
These encouraging macroscopic improvements served as the catalyst for a deeper biochemical investigation into the cellular environment within the animals’ kidneys and brains.
Different Protective Effects in the Kidneys and Brain
Upon examining the renal tissue, the investigators discovered that a high-salt diet substantially upregulated the expression of two key molecular components involved in prostaglandin signaling: cyclooxygenase-2, commonly known as COX-2, and the PGE2 receptor subtype EP3. Both of these proteins are strongly implicated in the genesis and progression of salt-sensitive hypertension.
The administration of LPC70 successfully suppressed these salt-induced elevations, indicating that the soy-derived compound helps correct aberrant renal signaling patterns that otherwise obstruct normal blood pressure control.
Conversely, a distinctly different molecular response was uncovered within the prefrontal cortex, a critical region of the brain responsible for executive function, long-term memory processing, and social cognition.
Excess dietary salt significantly diminished the expression of the PGD2 receptor known as DP1, which natively facilitates protective and anti-inflammatory signaling cascades within the neural tissue. Remarkably, treatment with LPC70 restored the expression levels of this beneficial receptor without triggering corresponding changes in DP2, a secondary receptor frequently associated with neurotoxic or otherwise harmful effects on nerve cells.
This precise pharmacological distinction is vital because it demonstrates that LPC70 does not act as a blunt instrument that indiscriminately amplifies or suppresses all prostaglandin activity. Instead, it appears to selectively favor signaling pathways that confer neuroprotection, providing a coherent biological explanation for the observed enhancements in memory and social behavior among the treated mice.
A Surprising Change in Chemical Signaling
In addition to mapping receptor expression, the research team uncovered an unexpected biochemical shift involving arachidonic acid, the essential precursor fatty acid utilized by the body for prostaglandin synthesis.
Mice consuming the high-salt diet exhibited markedly lower levels of circulating arachidonic acid. Yet, paradoxically, when these same animals received the LPC70 supplement, tissue concentrations of downstream prostaglandins derived from that fatty acid—including PGE2 and PGD2—actually increased.
This seemingly contradictory biochemical outcome suggests that LPC70 may optimize the body’s metabolic efficiency, enabling it to utilize available arachidonic acid pools more effectively to generate necessary prostaglandins even under the metabolic stress of high-salt conditions.
When viewed collectively, these experimental findings point toward a coordinated yet highly selective physiological response. Within the kidneys, LPC70 appears to downregulate signaling abnormalities tied directly to hypertension, whereas in the brain, it reactivates pathways dedicated to shielding neural tissue from inflammation and cellular damage. Consequently, the therapeutic impact of the compound relies heavily on both the anatomical site and the specific prostaglandin receptor profiles being modulated.
Could Soy-Based Ingredients Help Protect Against Excess Salt?
The implications of these findings suggest that LPC70 could eventually evolve into a valuable functional food ingredient designed to mitigate some of the most detrimental long-term health consequences linked to excessive dietary sodium intake.
Its demonstrated capacity to ameliorate both hypertension and cognitive deficits in animal models raises the intriguing possibility that similar dietary interventions could support human cardiovascular and neurological health, particularly among populations consuming high quantities of salt.
Nevertheless, researchers emphasize that these conclusions are derived entirely from preclinical animal models, and rigorous clinical trials involving human subjects will be mandatory before any therapeutic claims can be validated in clinical practice.
"Our study elucidates LPC70’s role in PG signaling, laying the groundwork for future clinical research and dietary interventions aimed at reducing hypertension-related cognitive decline and promoting healthy aging globally," concluded Prof. Mouri, summarizing the broader scope of the investigation.
Ultimately, the study provides a significantly clearer molecular picture of how a natural, soy-derived compound can systematically influence the human body’s systemic response to excess salt, opening promising new avenues for nutritional strategies aimed at safeguarding long-term health.
The research received financial backing through Grants-in-Aid for Scientific Research issued by the Japan Society for the Promotion of Science under reference numbers 20K07931, 22K07606, 22K11891, and 23H02843. Additional backing was delivered by the Fujita Mind-Brain Research and Innovation Center for Drug Generation through Japan’s Peak Research Universities Program under reference JPJS00420240019, alongside the Japan Science and Technology Agency FOREST Program under reference JPMJFR215H. Furthermore, operational funding was supplied directly by Tsuji Oil Mills Co., Ltd., complemented by institutional grants and support from the Education and Research Facility of Animal Models for Human Diseases at Fujita Health University, the Smoking Research Foundation, and the Takeda Science Foundation.